
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
Bruce Kneeland: How about immunizations, travel vaccines, those types of things?
Theresa Dickinson, RPh: We do immunizations, so we’ll do the flu shots for people. I guess some people pay for it, some people get their insurance to cover it, but either way people are coming to us for that.


